2 ms·
You wrote: <<automatically securing the rights to produce and distribute the patented good in developing nations>>. Real question for you and others: Where do
by throwaway2037 4y ago
You wrote: <<automatically securing the rights to produce and distribute the patented good in developing nations>>.
Real question for you and others: Where do we draw the line? That is an enormously complex question!
I have an equivalent to discuss: During the COVID-19 crisis, I was bothered that the South Africa gov't was pushing so hard to get access to produce vaccines locally without paying patent licensing costs. (Without very advanced pharma manuf facils, it would be useless. Many people under estimate the complexity of producing these new mRNA vaccines, let alone distributing them safely and correctly.) South Africa is, by many measures, a middle income economy. They could absolutely affort 10-20 USD per citizen to vaccinate their population -- not so different than what EU paid for vaccines. Please do not interpret this post as "dumping on SA"!. I just want to discuss a very specific example.
Related: The Serum Institute of India (which I think is the world's largest producer by vaccine doses) eventually secured a licenses to produce and sell vaccines. (Wiki tells me three were licensed [very impressive!]: AstraZeneca/Oxford, Novavax, and Russia's Gamaleya Sputnik V.) Does anyone know the details of SI's licensing agreements?